OCTREOSCAN

This brand name is authorized in Austria, France, Ireland, Japan, Singapore, Spain, UK.

Active ingredients

The drug OCTREOSCAN contains one active pharmaceutical ingredient (API):

1	Indium ¹¹¹In pentetreotide UNII 58TD96H03I - INDIUM CHLORIDE IN-111
	Indium(111In)pentetreotide specifically binds to receptors for somatostatin. After radiolabelling pentetreotide with indium( 111In)chloride, the solution obtained is indicated for use as adjunct in the diagnosis and management of receptor bearing gastro-entero-pancreatic neuroendocrine (GEP) tumours and carcinoid tumours, by aiding in their localisation.
	Read more about Indium ¹¹¹In pentetreotide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OCTREOSCAN Kit for radiopharmaceutical preparation	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09IB01	Indium (111In) pentetreotide	V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IB Indium (111In) compounds
Discover more medicines within V09IB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	60663
FR	Base de données publique des médicaments	62889478
GB	Medicines & Healthcare Products Regulatory Agency	399410
JP	医薬品医療機器総合機構	4300452G1026
SG	Health Sciences Authority	11244P